108768 ⎘
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor; Animal cells or tissues; Human cells or tissues; Vertebrate cells; Cells from the blood or the immune system; T lymphocytes Immunosuppressive T lymphocytes, e.g. regulatory T cells (Treg)
Regulatory T cells and methods of identifying, obtaining and using to treat immuno-based disorders
#602METHODS AND COMPOSITIONS FOR EXPANDING IMMUNOSUPPRESSIVE T REGULATORY CELLS IN VITRO AND USES THEREOF
#603IN VITRO METHOD FOR MODIFYING THE DEPLETION PROFILE OF TREG CELLS PRESENT IN A TOTAL SPLENOCYTE POPULATION OF A BIOLOGICAL SAMPLE BY MEANS OF THE ISOLATION, CULTURING AND EXPOSURE THEREOF TO AN ATP AND POLYMIXIN B MEDIUM
#604Modified epitopes for boosting CD4+ T-cell responses
#605CD4+ CD25+ T-CELLS ACTIVATED TO A SPECIFIC ANTIGEN
#606COMPOSITIONS AND METHODS FOR GENERATING INTERLEUKIN-35-INDUCED REGULATORY T CELLS
#607CELL POPULATIONS HAVING IMMUNOREGULATORY ACTIVITY, METHODS FOR THE PREPARATION AND USES THEREOF
#608Use of PDL1 expressing cells to convert T cells into regulatory T cells
#609Reprogramming T cells and hematopoietic cells
#610Soluble mediator
#611Nanoparticle compositions for generation of regulatory T cells and treatment of autoimmune diseases and other chronic inflammatory conditions
#612GPR15-mediated homing and uses thereof
#613T-REG Cell Expansion
#614Methods and compositions for modulating peripheral immune function
#615USE OF IGF-1 IN THE MODULATION OF TREG CELL ACTIVITY AND THE TREATMENT AND PREVENTION OF AUTOIMMUNE DISORDERS OR DISEASES
#616CHLAMYDIA-SPECIFIC CD8+ T CELLS AND METHODS OF ISOLATING
#617USE OF GENE REGULATORY NETWORK LOGIC FOR TRANSFORMATION OF CELLS
#618Treatment method for relapsing-remitting multiple sclerosis
#619Method for polyclonal stimulation of T cells by flexible nanomatrices
#620METHOD FOR EXPANDING CD4+CD25+T REGULATOR CELLS
#621Method for generating immunomodulatory cells, the cells prepared therefrom, and use thereof
#622Method for inducing immune tolerance using viable polymer-modified allogeneic leukocytes
#623Methods of Using Anti-Thymocyte Globulin and Related Agents
#624Serum Amyloid A (SAA) Overrides Regulatory T Cells (TREG) Anergy
#625Antibody and methods for selective inhibition of T-cell responses
#626COMPOSITIONS AND METHODS FOR PRODUCING ADAPTIVE REGULATORY T CELLS
#627Stable Tregs and related materials and methods
#628ANTIBODY AND METHODS FOR SELECTIVE INHIBITION OF T-CELL RESPONSES
#629PRODUCTION AND THERAPEUTIC USES OF TH1-LIKE REGULATORY T CELLS
#630Proteins that bind PI16 and uses thereof
#631Use of anti third party central memory T cells for anti-leukemia/lymphoma treatment
#632Methods and materials for the generation of regulatory T cells
#633Methods of producing T cell populations enriched for stable regulatory T-cells
#634Production method for cell populations
#635Regulatory immune cells with enhanced targeted cell death effect
#636Method of inhibiting progression of type 1 diabetes by administering soluble CD137
#637IL-13 PRODUCING TR1-LIKE CELLS AND USE THEREOF
#638Methods to Expand a T Regulatory Cell Master Cell Bank
#639Methods and compositions for modulating peripheral immune function
#640Methods and compositions for expanding and stabilizing natural regulatory T cells
#641ICOS critically regulates the expansion and function of inflammatory human Th17 cells
#642METHOD FOR THE IDENTIFICATION AND PURIFICATION OF HUMAN NATURALLY OCCURRING REGULATORY T CELLS (NTREGS)
#643Use of CCL1 in therapy
#644Cell populations having immunoregulatory activity, methods for the preparation and uses thereof
#645Regulatory B cells (tBREGS) and their use
#646TISSUE TRANSPLANT COMPOSITIONS AND METHODS FOR USE
#647TREATMENT OF SPINAL CORD INJURY AND TRAUMATIC BRAIN INJURY USING AMNION DERIVED ADHERENT CELLS
#648Enhancement of Allogeneic Hematopoietic Stem Cell Transplantation
#649Reprogramming T cells and hematopoietic cells
#650Targeting Antigens to Human Dendritic Cells Via DC-Asialoglycoprotein Receptor to Produce IL-10 Regulatory T-Cells
#651Methods and compositions for the generation and maintenance of regulatory T cells
#652BIOMARKERS AND USES THEREOF
#653COMPOSITIONS AND METHODS FOR GENERATING INTERLEUKIN-35-INDUCED REGULATORY T CELLS
#654Process for producing a human T-cell population having both cytotoxic and immunosuppressive activities
#655USE OF MEMBRANE ATTACK COMPLEX (MAC) AND IMMUNE COMPLEXES (ICs) TO ACTIVATE T-CELLS AND THE GENERATION OF REGULATORY T CELLS
#656MARKERS OF REGULATORY T CELL ACTIVATION
#657METHODS AND COMPOSITIONS TO ENHANCE VACCINE EFFICACY BY REPROGRAMMING REGULATORY T CELLS
#658Antigen Specific Tregs and related compositions, methods and systems
#659METHODS FOR THE ENRICHMENT OF VIABLE FOXP3+ CELLS AND USES THEREOF
#660COMPOSITIONS AND METHODS FOR RE-PROGRAMMING CELLS WITHOUT GENETIC MODIFICATION
#661VEHICLE FOR DELIVERING A COMPOUND TO A MUCOUS MEMBRANE AND RELATED COMPOSITIONS, METHODS AND SYSTEMS
#662Methods and compositions for inhibition of Treg cells
#663AGENT FOR THE TREATMENT AND/OR PROPHYLAXIS OF AN AUTOIMMUNE DISEASE AND FOR THE FORMATION OF REGULATORY T CELLS
#664Methods for Using Protein Kinase C-Theta Inhibitors in Adoptive Immunotherapy
#665AUGMENTATION OF CELL THERAPY EFFICACY INCLUDING TREATMENT WITH ALPHA 1-3 FUCOSYLTRANSFERASE
#666MFAP4 as a Marker For Regulatory Cells and Anti-Cancer Cells
#667COMPOSITIONS FOR TREATING AN INFLAMMATORY AUTOIMMUNE CONDITION
#668COMPOSITIONS FOR TREATING AN ARTHRITIC CONDITION
#669METHOD FOR EX-VIVO EXPANSION OF REGULATORY T CELLS WITH ENHANCED SUPPRESSIVE FUNCTION FOR CLINICAL APPLICATION IN IMMUNE MEDIATED DISEASES
#670Treatment methods for autoimmune disorders
#671Compositions for treating multiple sclerosis
#672Compositions and methods for producing adaptive regulatory T cells
#673METHODS AND MATERIALS FOR THE GENERATION OF REGULATORY T CELLS
#674Anti-tumour vaccine derived from normal cells
#675METHODS AND MATERIALS FOR THE GENERATION OF REGULATORY T CELLS
#676Tolerogenic dendritic cells, method for their production and uses therof
#677Use of PI3K M-TOR and Akt Inhibitors to Induce FOXP3 Expression and Generate Regulatory T Cells
#678Methods of Using Anti-Thymocyte Globulin and Related Agents
#679Specific CD4+CD25+ Regulatory T Cells for Haematopoietic Cell Transplantation and Immune Tolerance
#680Isolation and Use of Human Regulatory T Cells
#681Method for expanding Cd4+ Cd25+ T regulator cells
#682Cd4+ Cd25+ T-cells activated to a specific antigen
#683Use of apoptotic cells ex vivo to generate regulatory T cells
#684Production And Therapeutic Uses Of Th1-Like Regulatory T Cells
#685Use of apoptotic cells ex vivo to generate regulatory T Cells
#686Novel methods, compositions and devices for inducing neovascularization
#687Tolerogenic vaccine and method